-transparent.png){kind=logo}
The existence of an increasing number of apparently healthy carriers of the HBsAg demands a specific assisting attitude which must be highly reliable without increasing health care expenses. With that purpose, 129 asymptomatic carriers without prior history of jaundice and/or alcohol abuse were studied. The following discriminant criteria were used: hepatomegaly, other physical evidence of liver disease, hypertransaminasemia, and sulfobromophthalein retention. The carrier was defined as healthy after two consecutive examinations disclosing no abnormalities at intervals of six months, which occurred in 108 patients (84 %). No patient underwent liver biopsy, but the examination was still normal after two years in all cases. The presence of one or more abnormal findings was an indication for liver biopsy in 21 patients (16 %), and the procedure was accepted by 11 (52 %). The efficiency of the selection method was evaluated according to the histologic findings. The most useful criteria were hypertransaminasemia and sulfobromophthalein retention, in this order.
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
January 1975,
Revista medica de Chile,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
March 1974,
Casopis lekaru ceskych,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
October 1975,
Medizinische Klinik,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
May 1973,
Journal of clinical pathology,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
October 1978,
La Nouvelle presse medicale,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
February 1975,
Acta hepato-gastroenterologica,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
December 1973,
Munchener medizinische Wochenschrift (1950),
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
September 1975,
Rinsho byori. The Japanese journal of clinical pathology,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
June 1978,
Quaderni Sclavo di diagnostica clinica e di laboratorio,
M D Simó Falcó, and
E Lissen Otero, and
R Caraballo Guijarro, and
A Sánchez Quijano, and
F García de Pesquera, and
R Castro Artigas, and
M Leal Noval, and
F Andreu Kern
April 1974,
Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
